Enzymedica President Shares Information at Cancer Control Society's Annual Convention

35th Annual Event Addresses Alternative Therapies Used In Cancer Treatment

PORT CHARLOTTE, Fla., Sept. 6, 2007 — Enzymedica, Inc. today confirmed that company president and enzymes author Tom Bohager presented at the 35th Annual Cancer Convention, held Sept. 1-3 in Universal City, Calif.

Author of "Enzymes: What the Experts Know," Bohager discussed the role of enzymes in cancer therapy on Monday, Sept. 3. Coordinated by the Cancer Control Society and featuring more than 50 speakers, the yearly convention brings together medical doctors, clinical researchers, nutritionists and authors to inform the public about alternative methods for the prevention and control of cancer and related diseases.

"The role of plant-based enzymes in both addressing illness and for overall health holds some interesting findings," said Bohager. "With the Cancer Control Society's recognition of nutrition's part in cancer prevention and treatment, I was honored to share some helpful information while at the same time learning about the advances in other alternative therapies."

To find about more about the Cancer Control Society, visit www.cancercontrolsociety.com.

About Enzymedica, Inc.:
Florida-based Enzymedica, Inc., was founded in 1998 to offer consumers targeted enzyme products that address digestion issues, food allergies and intolerances, cardiovascular issues, immune function and inflammation. The exclusive Enzymedica Thera-blend(TM) process combines different strains of each major enzyme to work more broadly in the digestive tract and throughout the entire body. Enzymedica's products are made from only the highest quality plant and plant-based enzymes and are 100 percent vegan and vegetarian.

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.